Meds & supplements › Mifepristone
Medicine · Progestin Antagonist
KORLYM (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have…
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
WARNING: TERMINATION OF PREGNANCY Mifepristone is a potent antagonist of progesterone and cortisol via the progesterone and glucocorticoid (GR-II) receptors, respectively. The antiprogestational effects will result in the termination of pregnancy. Pregnancy must therefore be excluded before the initiation of treatment with KORLYM and prevented during treatment and for one month after stopping treatment by the use of a non-hormonal medically acceptable method of contraception unless the patient has had a surgical sterilization, in which case no additional contraception is needed. Pregnancy must also be excluded if treatment is interrupted for more than 14 days in females of reproductive potential. WARNING: TERMINATION OF PREGNANCY See full prescribing information for complete boxed warning. Mifepristone has potent antiprogestational effects and will result in the termination of pregnancy. Pregnancy must therefore be excluded before the initiation of treatment with KORLYM, or if treatment is interrupted for more than 14 days in females of reproductive potential.
KORLYM (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. LIMITATIONS OF USE: KORLYM should not be used in the treatment of patients with type 2 diabetes unless it is secondary to Cushing's syndrome.
KORLYM (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Important Limitations of Use: Do not use for the treatment of type 2 diabetes mellitus unrelated to endogenous Cushing's syndrome.
KORLYM can cause serious side effects, including: Loss of a pregnancy. Women who can become pregnant must: have a negative pregnancy test before starting KORLYM have a negative pregnancy test before restarting KORLYM if you stop taking it for more than 14 days use a non-hormonal form of birth control while taking KORLYM and for 1 month after stopping KORLYM.
Talk to your doctor about how to prevent pregnancy. Tell your doctor right away if you think you may be pregnant. What is KORLYM? KORLYM is a prescription medicine used to treat high blood sugar (hyperglycemia) caused by high cortisol levels in the blood (hypercortisolism) in adults with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or cannot have surgery.
KORLYM is not for people who have type 2 diabetes mellitus not caused by Cushing's syndrome. It is not known if KORLYM is safe and effective in children.
Take KORLYM exactly as your doctor tells you. Your doctor may change your dose if needed. KORLYM is usually taken 1 time each day. Take KORLYM with food. Swallow KORLYM whole. Do not split, crush or chew KORLYM tablets. If you cannot swallow KORLYM tablets whole, tell your doctor.
KORLYM can cause serious side effects including: loss of pregnancy reduced effects of adrenal hormones (adrenal insufficiency). KORLYM stops an adrenal hormone in your body called cortisol from working. Tell your doctor right away if you have any symptoms of adrenal insufficiency. Symptoms may include: unusual tiredness or weakness nausea fatigue low blood pressure (hypotension) low blood sugar (hypoglycemia) low blood potassium (hypokalemia).
Your doctor should check the level of potassium in your blood before you start taking KORLYM and while you take it. Tell your doctor if you have any signs of low potassium. Signs may include: muscle weakness, aches, or cramps abnormal or irregular heartbeats (palpitations) bleeding from the vagina. KORLYM may cause the lining of your uterus to become thick and may cause your uterus to bleed.
Tell your doctor right away about any bleeding from your vagina that is not normal for you. disruption of menstrual cycle problems with the electrical system of your heart (QT interval prolongation). worsening of symptoms of other medical problems that are treated with corticosteroids when you take corticosteroids and KORLYM at the same time.
The most common side effects of KORLYM include: nausea headache pain in your arms and legs (arthralgia) swelling of your arms and legs (peripheral edema) dizziness thickening of the lining of the uterus (endometrial hypertrophy) fatigue low potassium in your blood vomiting high blood pressure decreased appetite Tell your doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of KORLYM. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
” are taking: simvastatin (Zocor ®, Vytorin ®, Simcor ® ) lovastatin (Mevacor ®, Altoprev ®, Advicor ® ) cyclosporine (Gengraf ®, Neoral ®, Restasis ®, Sandimmune ® ) dihydroergotamine (Migranal ® ) ergotamine (Ergomar ®, Migergot ® ) fentanyl (Abstral ®, Actiq ®, Duragesic ®, Fentora ®, Lazanda ®, Onsolis ®, Sublimaze Preservative Free ®, Subsys ® ) pimozide (Orap ® ) quinidine (Nuedexta ® ) sirolimus (Rapamune ®, Torisel ® ) tacrolimus (Prograf ®, Protopic ® ) must take corticosteroid medicines for other serious medical problems are a woman who still has her uterus (womb) and have: unexplained bleeding from your vagina changes in the cells lining your uterus (endometrial hyperplasia) or cancer of the lining of your uterus (endometrial cancer) are allergic to mifepristone or any of the ingredients in KORLYM.
See the end of this Medication Guide for a complete list of ingredients in KORLYM. Talk to your doctor before taking KORLYM if you have any of these conditions.
Before taking KORLYM, tell your doctor if you: are pregnant or plan to become pregnant have low potassium in your blood (hypokalemia) have or have had a bleeding problem or are taking medicines to thin your blood have or have had heart problems have had an organ transplant have been taking medicines called corticosteroids (cortisone, dexamethasone, methylprednisolone, prednisolone, prednisone) are breastfeeding or plan to breastfeed.
Tell your doctor about all of the medicines you take, including prescription and nonprescription medicines, vitamins and herbal supplements. Using KORLYM with certain other medicines can affect each other. Using KORLYM with other medicines can cause serious side effects. Especially tell your doctor if you take: medicines to treat: fungal infections (such as ketoconazole) depression HIV infection Hepatitis C infection certain bacterial infections high blood pressure steroid medicines such as prednisone thyroid hormones Ask your doctor or pharmacist for a list of these medicines if you are not sure.
Know the medicines you take. Keep a list of them to show to your doctor and pharmacist.
You should not drink grapefruit juice while you take KORLYM. Grapefruit juice may increase the amount of KORLYM in your blood and increase your chance of having side effects.
Store KORLYM at room temperature, between 68°F to 77°F (20°C to 25°C). Keep KORLYM and all medicines out of the reach of children.
sofidex [Internet]. Daloreum; c2026. Mifepristone; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/mifepristone
sofidex. (2026, August 2). Mifepristone. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/mifepristone
Mifepristone. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/mifepristone
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.